Price target
916.220.000.00%
The 16 analysts offering 1 year price forecasts for GSK/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 22 analysts giving stock ratings to GSK/N in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GSK/N EPS for the last quarter is 25.48 MXN despite the estimation of 22.70 MXN. In the next quarter EPS is expected to reach 10.45 MXN. Track more of GSK PLC financials and stay on top of what is up with the company.
In the next quarter GSK PLC revenue is expected to reach 203.07 B MXN. Check out GSK PLC revenue and earnings and make informed decisions.
According to analysts, GSK/N price target is 916.22 MXN with a max estimate of 1,387.78 MXN and a min estimate of 696.82 MXN. Check if this forecast comes true in a year, meanwhile watch GSK PLC stock price chart and keep track of the current situation with GSK/N news and stock market news.
We've gathered opinions of 22 analysts rating GSK/N stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.